Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Clinical complications in envenoming by Apis honeybee stings: insights into mechanisms, diagnosis, and pharmacological interventions

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Envenoming resulting from Apis honeybee stings pose a neglected public health concern, with clinical complications ranging from mild local reactions to severe systemic manifestations. This review explores the mechanisms underlying envenoming by honeybee sting, discusses diagnostic approaches, and reviews current pharmacological interventions. This section explores the diverse clinical presentations of honeybee envenoming, including allergic and non-allergic reactions, emphasizing the need for accurate diagnosis to guide appropriate medical management. Mechanistic insights into the honeybee venom’s impact on physiological systems, including the immune and cardiovascular systems, are provided to enhance understanding of the complexities of honeybee sting envenoming. Additionally, the article evaluates emerging diagnostic technologies and therapeutic strategies, providing a critical analysis of their potential contributions to improved patient outcomes. This article aims to provide current knowledge for healthcare professionals to effectively manage honeybee sting envenoming, thereby improving patient care and treatment outcomes.

          Related collections

          Most cited references210

          • Record: found
          • Abstract: found
          • Article: not found

          Ferroptosis: mechanisms, biology and role in disease

          The research field of ferroptosis has seen exponential growth over the past few years, since the term was coined in 2012. This unique modality of cell death, driven by iron-dependent phospholipid peroxidation, is regulated by multiple cellular metabolic pathways, including redox homeostasis, iron handling, mitochondrial activity and metabolism of amino acids, lipids and sugars, in addition to various signalling pathways relevant to disease. Numerous organ injuries and degenerative pathologies are driven by ferroptosis. Intriguingly, therapy-resistant cancer cells, particularly those in the mesenchymal state and prone to metastasis, are exquisitely vulnerable to ferroptosis. As such, pharmacological modulation of ferroptosis, via both its induction and its inhibition, holds great potential for the treatment of drug-resistant cancers, ischaemic organ injuries and other degenerative diseases linked to extensive lipid peroxidation. In this Review, we provide a critical analysis of the current molecular mechanisms and regulatory networks of ferroptosis, the potential physiological functions of ferroptosis in tumour suppression and immune surveillance, and its pathological roles, together with a potential for therapeutic targeting. Importantly, as in all rapidly evolving research areas, challenges exist due to misconceptions and inappropriate experimental methods. This Review also aims to address these issues and to provide practical guidelines for enhancing reproducibility and reliability in studies of ferroptosis. Finally, we discuss important concepts and pressing questions that should be the focus of future ferroptosis research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Ferroptosis: molecular mechanisms and health implications

            Cell death can be executed through different subroutines. Since the description of ferroptosis as an iron-dependent form of non-apoptotic cell death in 2012, there has been mounting interest in the process and function of ferroptosis. Ferroptosis can occur through two major pathways, the extrinsic or transporter-dependent pathway and the intrinsic or enzyme-regulated pathway. Ferroptosis is caused by a redox imbalance between the production of oxidants and antioxidants, which is driven by the abnormal expression and activity of multiple redox-active enzymes that produce or detoxify free radicals and lipid oxidation products. Accordingly, ferroptosis is precisely regulated at multiple levels, including epigenetic, transcriptional, posttranscriptional and posttranslational layers. The transcription factor NFE2L2 plays a central role in upregulating anti-ferroptotic defense, whereas selective autophagy may promote ferroptotic death. Here, we review current knowledge on the integrated molecular machinery of ferroptosis and describe how dysregulated ferroptosis is involved in cancer, neurodegeneration, tissue injury, inflammation, and infection.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch.

              Mammals have evolved neurophysiologic reflexes, such as coughing and scratching, to expel invading pathogens and noxious environmental stimuli. It is well established that these responses are also associated with chronic inflammatory diseases, including asthma and atopic dermatitis. However, the mechanisms by which inflammatory pathways promote sensations such as itch remain poorly understood. Here, we show that type 2 cytokines directly activate sensory neurons in both mice and humans. Further, we demonstrate that chronic itch is dependent on neuronal IL-4Rα and JAK1 signaling. We also observe that patients with recalcitrant chronic itch that failed other immunosuppressive therapies markedly improve when treated with JAK inhibitors. Thus, signaling mechanisms previously ascribed to the immune system may represent novel therapeutic targets within the nervous system. Collectively, this study reveals an evolutionarily conserved paradigm in which the sensory nervous system employs classical immune signaling pathways to influence mammalian behavior.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2735432Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2829690Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2756843Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2829778Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2829772Role: Role: Role:
                Role:
                URI : https://loop.frontiersin.org/people/2830877Role:
                URI : https://loop.frontiersin.org/people/764581Role: Role: Role:
                URI : https://loop.frontiersin.org/people/41350Role: Role:
                URI : https://loop.frontiersin.org/people/936687Role: Role: Role: Role: Role: Role:
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                18 September 2024
                2024
                : 15
                : 1437413
                Affiliations
                [1] 1 Graduate Program in Tropical Diseases, Botucatu Medical School (FMB), São Paulo State University (UNESP) , Botucatu, São Paulo, Brazil
                [2] 2 Department of Bioprocess and Biotechnology, School of Agriculture, Agronomic Sciences School, São Paulo State University (UNESP) , Botucatu, São Paulo, Brazil
                [3] 3 Center for the Study of Venoms and Venomous Animals of UNESP (CEVAP), São Paulo State University (UNESP) , Botucatu, São Paulo, Brazil
                [4] 4 Minas Gerais Toxicological Information and Assistance Center, João XXIII Hospital , Belo Horizonte, Minas Gerais, Brazil
                [5] 5 Graduate Program in Tropical Medicine of the State University of Amazonas , Manaus, Amazonas, Brazil
                [6] 6 Department of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University (UNESP) , Araraquara, São Paulo, Brazil
                [7] 7 Center for Translational Science and Development of Biopharmaceuticals FAPESP/CEVAP-UNESP , Botucatu, São Paulo, Brazil
                Author notes

                Edited by: Dale Umetsu, Stanford University, United States

                Reviewed by: Mouzarllem Barros Reis, University of São Paulo, Brazil

                Vanessa de Fátima Borges, Cedars Sinai Medical Center, United States

                *Correspondence: Rui Seabra Ferreira Junior, rui.seabra@ 123456unesp.br
                Article
                10.3389/fimmu.2024.1437413
                11445026
                39359723
                eddfb2f7-637a-42d2-bbda-4be585fb7ffa
                Copyright © 2024 Cavalcante, Riciopo, Pereira, Jeronimo, Angstmam, Pôssas, Andrade Filho, Cerni, Pucca and Ferreira Junior

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 23 May 2024
                : 20 August 2024
                Page count
                Figures: 3, Tables: 2, Equations: 0, References: 212, Pages: 18, Words: 6188
                Funding
                Funded by: Fundação de Amparo à Pesquisa do Estado de São Paulo , doi 10.13039/501100001807;
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The APC was funded by FAPESP Proc 2021/11936-3 (RF). We are thankful to the Coordination of Superior Level Staff Improvement (CAPES) for the scholarship n° 88887.674376/2022-00 (JC) and 88887.826358/2023-00 (DA), and the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, São Paulo Research Foundation), scholarships to JC n° 2022/16060-1, to AP n° 2023/09921-3, FAPESP Process 2021/11936-3 and 2023/01554-1 (RF). We also thank the The National Council for Scientific and Technological Development (CNPq) scholarship to MP n° 305778/2023-4 and to AP n° 151190/2023-2, and the Fundação de Amparo à Pesquisa do Estado do Amazonas (FAPEAM), scholarship to FC n° 01.02.016301.01070/2023-13. RF is a CNPq PQ1C fellow researcher 303224/2018-5 and CNPq PQ1D research fellow n° 301608/2022-9. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001.
                Categories
                Immunology
                Review
                Custom metadata
                Inflammation

                Immunology
                bee venom,bee sting,clinical envenoming,clinical management,venomous animals,africanized bee,honeybee

                Comments

                Comment on this article